Alphatec (ATEC) Competitors

Alphatec has a net margin of -13.49% compared to Teleflex's net margin of -39.67%. Teleflex's return on equity of 11.93% beat Alphatec's return on equity.

66.4% of Alphatec shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 13.5% of Alphatec shares are held by insiders. Comparatively, 0.7% of Teleflex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Alphatec has higher earnings, but lower revenue than Teleflex. Alphatec is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Alphatec has a beta of 0.78, indicating that its share price is 22% less volatile than the broader market. Comparatively, Teleflex has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market.

In the previous week, Alphatec had 2 more articles in the media than Teleflex. MarketBeat recorded 5 mentions for Alphatec and 3 mentions for Teleflex. Alphatec's average media sentiment score of 0.63 beat Teleflex's score of 0.00 indicating that Alphatec is being referred to more favorably in the media.

Alphatec presently has a consensus target price of $17.40, indicating a potential upside of 63.07%. Teleflex has a consensus target price of $155.20, indicating a potential upside of 24.15%. Given Alphatec's stronger consensus rating and higher probable upside, equities analysts plainly believe Alphatec is more favorable than Teleflex.

Haemonetics has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, Alphatec has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market.

In the previous week, Haemonetics had 14 more articles in the media than Alphatec. MarketBeat recorded 19 mentions for Haemonetics and 5 mentions for Alphatec. Alphatec's average media sentiment score of 0.63 beat Haemonetics' score of 0.52 indicating that Alphatec is being referred to more favorably in the news media.

Haemonetics presently has a consensus price target of $110.00, suggesting a potential downside of 7.45%. Alphatec has a consensus price target of $17.40, suggesting a potential upside of 63.07%. Given Alphatec's stronger consensus rating and higher probable upside, analysts clearly believe Alphatec is more favorable than Haemonetics.

99.7% of Haemonetics shares are held by institutional investors. Comparatively, 66.4% of Alphatec shares are held by institutional investors. 2.1% of Haemonetics shares are held by insiders. Comparatively, 13.5% of Alphatec shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Haemonetics has a net margin of 7.12% compared to Alphatec's net margin of -13.49%. Haemonetics' return on equity of 27.55% beat Alphatec's return on equity.

Haemonetics has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Integer has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market. Comparatively, Alphatec has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market.

In the previous week, Alphatec had 1 more articles in the media than Integer. MarketBeat recorded 5 mentions for Alphatec and 4 mentions for Integer. Alphatec's average media sentiment score of 0.63 beat Integer's score of 0.27 indicating that Alphatec is being referred to more favorably in the news media.

Integer presently has a consensus price target of $109.86, suggesting a potential downside of 13.25%. Alphatec has a consensus price target of $17.40, suggesting a potential upside of 63.07%. Given Alphatec's stronger consensus rating and higher possible upside, analysts clearly believe Alphatec is more favorable than Integer.

Integer has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Integer has a net margin of 6.97% compared to Alphatec's net margin of -13.49%. Integer's return on equity of 12.79% beat Alphatec's return on equity.

99.3% of Integer shares are held by institutional investors. Comparatively, 66.4% of Alphatec shares are held by institutional investors. 1.1% of Integer shares are held by insiders. Comparatively, 13.5% of Alphatec shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

66.4% of Alphatec shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 13.5% of Alphatec shares are owned by insiders. Comparatively, 0.4% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, LivaNova had 3 more articles in the media than Alphatec. MarketBeat recorded 8 mentions for LivaNova and 5 mentions for Alphatec. LivaNova's average media sentiment score of 0.71 beat Alphatec's score of 0.63 indicating that LivaNova is being referred to more favorably in the news media.

Alphatec currently has a consensus price target of $17.40, indicating a potential upside of 63.07%. LivaNova has a consensus price target of $87.75, indicating a potential upside of 14.87%. Given Alphatec's stronger consensus rating and higher possible upside, analysts clearly believe Alphatec is more favorable than LivaNova.

Alphatec has higher earnings, but lower revenue than LivaNova. Alphatec is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Alphatec has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market.

LivaNova has a net margin of 12.82% compared to Alphatec's net margin of -13.49%. LivaNova's return on equity of 16.35% beat Alphatec's return on equity.